- Home
- KRMD vs HLN Comparison
KRMD vs HLN Comparison
Compare KRMD & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- HLN
- Stock Information
- Founded
- KRMD 1980
- HLN 2022
- Country
- KRMD United States
- HLN United Kingdom
- Employees
- KRMD N/A
- HLN N/A
- Industry
- KRMD Medical/Dental Instruments
- HLN Package Goods/Cosmetics
- Sector
- KRMD Health Care
- HLN Consumer Discretionary
- Exchange
- KRMD Nasdaq
- HLN Nasdaq
- Market Cap
- KRMD 103.4M
- HLN 45.6B
- IPO Year
- KRMD N/A
- HLN N/A
- Fundamental
- Price
- KRMD $2.47
- HLN $10.19
- Analyst Decision
- KRMD Strong Buy
- HLN Buy
- Analyst Count
- KRMD 4
- HLN 1
- Target Price
- KRMD $4.88
- HLN $10.95
- AVG Volume (30 Days)
- KRMD 145.7K
- HLN 15.0M
- Earning Date
- KRMD 05-07-2025
- HLN 02-27-2025
- Dividend Yield
- KRMD N/A
- HLN 1.65%
- EPS Growth
- KRMD N/A
- HLN 38.94
- EPS
- KRMD N/A
- HLN 0.20
- Revenue
- KRMD $33,646,463.00
- HLN $14,062,871,660.00
- Revenue This Year
- KRMD $16.50
- HLN $5.66
- Revenue Next Year
- KRMD $15.47
- HLN $4.86
- P/E Ratio
- KRMD N/A
- HLN $25.12
- Revenue Growth
- KRMD 17.98
- HLN N/A
- 52 Week Low
- KRMD $1.86
- HLN $8.12
- 52 Week High
- KRMD $5.05
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- KRMD 46.18
- HLN 52.01
- Support Level
- KRMD $2.36
- HLN $10.14
- Resistance Level
- KRMD $2.52
- HLN $10.34
- Average True Range (ATR)
- KRMD 0.22
- HLN 0.23
- MACD
- KRMD 0.06
- HLN 0.04
- Stochastic Oscillator
- KRMD 91.04
- HLN 75.28
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.